menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Xeroderma Pigmentosum in the Crosshairs: A Dermatologist's Journey to Guatemala, Part 2

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
  • Overview

    Imagine that you have a rare condition called Xeroderma Pigmentosum (XP) in which even the slightest amount of UV radiation from the Sun turns your skin to cancer; left untreated, you can expect to die within the first 10 years of your life. Also imagine that your brothers and sisters suffer from this same affliction, but your family lacks the resources to do anything about it.

    Join Dr. Andrew Krakowski as he joins Dr. Bari Cuningham to discuss her remarkable journey through the wilderness of Guatemala to a small town where an autosomal recessive disease has dominated the local population and cast a shadow on life in this village. Then hear how a new day may be dawning for these special people thanks to a support team that is now championing their cause.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Imagine that you have a rare condition called Xeroderma Pigmentosum (XP) in which even the slightest amount of UV radiation from the Sun turns your skin to cancer; left untreated, you can expect to die within the first 10 years of your life. Also imagine that your brothers and sisters suffer from this same affliction, but your family lacks the resources to do anything about it.

    Join Dr. Andrew Krakowski as he joins Dr. Bari Cuningham to discuss her remarkable journey through the wilderness of Guatemala to a small town where an autosomal recessive disease has dominated the local population and cast a shadow on life in this village. Then hear how a new day may be dawning for these special people thanks to a support team that is now championing their cause.

Facebook Comments

Schedule19 Apr 2024